XOFLUZA FDA approval date

The FDA approved XOFLUZA on 24 Oct 2018.

FDA approval date
24 Oct 2018

Drug identity has not yet been verified against registry records

Also recorded as BALOXAVIR MARBOXIL

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-10-24DayXOFLUZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210854", "applicant_as_listed_by_fda": "GENENTECH INC", "brand_names": ["XOFLUZA"], "active_ingredients": ["BALOXAVIR MARBOXIL"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20181024", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026